ID

39983

Beschreibung

MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352); ODM derived from: https://clinicaltrials.gov/show/NCT01307046

Link

https://clinicaltrials.gov/show/NCT01307046

Stichworte

Versionen (1)
  1. 08.03.20 08.03.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. März 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hypertension NCT01307046

Englisch

Eligibility Hypertension NCT01307046

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant has a diagnosis of essential hypertension.
Beschreibung

Essential Hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C0085580
participant is not treated with antihypertensive medication and meets protocol-specified blood pressure criteria.
Beschreibung

Antihypertensive Agents Absent | Blood Pressure Criteria Study Protocol | Blood Pressure Criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0005823
UMLS CUI [2,2]
C0243161
UMLS CUI [2,3]
C2348563
UMLS CUI [3,1]
C0005823
UMLS CUI [3,2]
C0243161
UMLS CUI [3,3]
C1550543
participant is treated with single antihypertensive medication, and meets protocol-specified blood pressure criteria.
Beschreibung

Antihypertensive Agent Single | Blood Pressure Criteria Study Protocol | Blood Pressure Criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0205171
UMLS CUI [2,1]
C0005823
UMLS CUI [2,2]
C0243161
UMLS CUI [2,3]
C2348563
UMLS CUI [3,1]
C0005823
UMLS CUI [3,2]
C0243161
UMLS CUI [3,3]
C1550543
participant is being treated with up to dual oral antihypertensive medications, and will be able to discontinue the prior antihypertensive medication.
Beschreibung

Antihypertensive Agents Quantity | Ability Discontinue Antihypertensive Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0085732
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C0003364
participant has no clinically meaningful findings to be disqualified from the study at the discretion of the investigator.
Beschreibung

Ineligibility Findings Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0037088
UMLS CUI [1,3]
C0332197
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
regarding hypertension, participant is currently taking > 2 antihypertensive medications.
Beschreibung

Antihypertensive Agents Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
participant has a history of significant multiple and/or severe allergies to ingredients of nu-lotan or preminent and thiazide drug or related drug (i.e., sulfonamide-containing "chlortalidone" medicines)
Beschreibung

Multiple allergies Ingredient Losartan Potassium | Severe allergy Ingredient Losartan Potassium | Multiple allergies Ingredient Preminent | Severe allergy Ingredient Preminent | Multiple allergies Ingredient Thiazide | Severe allergy Ingredient Thiazide | Multiple allergies Ingredient Chlorthalidone | Severe allergy Ingredient Chlorthalidone

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0740281
UMLS CUI [1,2]
C1550600
UMLS CUI [1,3]
C0700492
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C1550600
UMLS CUI [2,3]
C0700492
UMLS CUI [3,1]
C0740281
UMLS CUI [3,2]
C1550600
UMLS CUI [3,3]
C0138304
UMLS CUI [4,1]
C2945656
UMLS CUI [4,2]
C1550600
UMLS CUI [4,3]
C0138304
UMLS CUI [5,1]
C0740281
UMLS CUI [5,2]
C1550600
UMLS CUI [5,3]
C0541746
UMLS CUI [6,1]
C2945656
UMLS CUI [6,2]
C1550600
UMLS CUI [6,3]
C0541746
UMLS CUI [7,1]
C0740281
UMLS CUI [7,2]
C1550600
UMLS CUI [7,3]
C0008294
UMLS CUI [8,1]
C2945656
UMLS CUI [8,2]
C1550600
UMLS CUI [8,3]
C0008294
participant is, at the time of signing informed consent, a user of recreational or illicit drugs or a recent history within the last year of drug or alcohol abuse or dependence.
Beschreibung

Recreational drug use | Illicit medication use | Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0281875
UMLS CUI [3]
C0038586
participant is pregnant or breastfeeding or expecting to conceive or has a positive pregnancy test at the screening visit.
Beschreibung

Pregnancy | Breast Feeding | Pregnancy, Planned | Pregnancy test positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4]
C0240802
participant is currently participating or has participated in a study with an investigational compound (except losartan at any doses) or device within 30 days of signing informed consent.
Beschreibung

Study Subject Participation Status | Investigational New Drugs | Exception Losartan Dose Any | Investigational Medical Device

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0126174
UMLS CUI [3,3]
C0178602
UMLS CUI [3,4]
C1552551
UMLS CUI [4]
C2346570
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hypertension NCT01307046

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Essential Hypertension
Item
participant has a diagnosis of essential hypertension.
boolean
C0085580 (UMLS CUI [1])
Antihypertensive Agents Absent | Blood Pressure Criteria Study Protocol | Blood Pressure Criteria Fulfill
Item
participant is not treated with antihypertensive medication and meets protocol-specified blood pressure criteria.
boolean
C0003364 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0005823 (UMLS CUI [2,1])
C0243161 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
C0005823 (UMLS CUI [3,1])
C0243161 (UMLS CUI [3,2])
C1550543 (UMLS CUI [3,3])
Antihypertensive Agent Single | Blood Pressure Criteria Study Protocol | Blood Pressure Criteria Fulfill
Item
participant is treated with single antihypertensive medication, and meets protocol-specified blood pressure criteria.
boolean
C0003364 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C0005823 (UMLS CUI [2,1])
C0243161 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
C0005823 (UMLS CUI [3,1])
C0243161 (UMLS CUI [3,2])
C1550543 (UMLS CUI [3,3])
Antihypertensive Agents Quantity | Ability Discontinue Antihypertensive Agents
Item
participant is being treated with up to dual oral antihypertensive medications, and will be able to discontinue the prior antihypertensive medication.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0003364 (UMLS CUI [2,3])
Ineligibility Findings Absent
Item
participant has no clinically meaningful findings to be disqualified from the study at the discretion of the investigator.
boolean
C1512714 (UMLS CUI [1,1])
C0037088 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Antihypertensive Agents Quantity
Item
regarding hypertension, participant is currently taking > 2 antihypertensive medications.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Multiple allergies Ingredient Losartan Potassium | Severe allergy Ingredient Losartan Potassium | Multiple allergies Ingredient Preminent | Severe allergy Ingredient Preminent | Multiple allergies Ingredient Thiazide | Severe allergy Ingredient Thiazide | Multiple allergies Ingredient Chlorthalidone | Severe allergy Ingredient Chlorthalidone
Item
participant has a history of significant multiple and/or severe allergies to ingredients of nu-lotan or preminent and thiazide drug or related drug (i.e., sulfonamide-containing "chlortalidone" medicines)
boolean
C0740281 (UMLS CUI [1,1])
C1550600 (UMLS CUI [1,2])
C0700492 (UMLS CUI [1,3])
C2945656 (UMLS CUI [2,1])
C1550600 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
C0740281 (UMLS CUI [3,1])
C1550600 (UMLS CUI [3,2])
C0138304 (UMLS CUI [3,3])
C2945656 (UMLS CUI [4,1])
C1550600 (UMLS CUI [4,2])
C0138304 (UMLS CUI [4,3])
C0740281 (UMLS CUI [5,1])
C1550600 (UMLS CUI [5,2])
C0541746 (UMLS CUI [5,3])
C2945656 (UMLS CUI [6,1])
C1550600 (UMLS CUI [6,2])
C0541746 (UMLS CUI [6,3])
C0740281 (UMLS CUI [7,1])
C1550600 (UMLS CUI [7,2])
C0008294 (UMLS CUI [7,3])
C2945656 (UMLS CUI [8,1])
C1550600 (UMLS CUI [8,2])
C0008294 (UMLS CUI [8,3])
Recreational drug use | Illicit medication use | Substance Use Disorders
Item
participant is, at the time of signing informed consent, a user of recreational or illicit drugs or a recent history within the last year of drug or alcohol abuse or dependence.
boolean
C0013146 (UMLS CUI [1])
C0281875 (UMLS CUI [2])
C0038586 (UMLS CUI [3])
Pregnancy | Breast Feeding | Pregnancy, Planned | Pregnancy test positive
Item
participant is pregnant or breastfeeding or expecting to conceive or has a positive pregnancy test at the screening visit.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0240802 (UMLS CUI [4])
Study Subject Participation Status | Investigational New Drugs | Exception Losartan Dose Any | Investigational Medical Device
Item
participant is currently participating or has participated in a study with an investigational compound (except losartan at any doses) or device within 30 days of signing informed consent.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0126174 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C1552551 (UMLS CUI [3,4])
C2346570 (UMLS CUI [4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video